Pharmaceutical Industry and FDA Use Mob Tactics to Silence Whistleblowers
Peter Gøtzsche argues that we should consider allowing whistleblowers to publish anonymously for their safety.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
